Skip to main content
. 2022 Apr 1;12:846044. doi: 10.3389/fonc.2022.846044

Table 2.

Univariate analyses for PFS and OS in 122 MDS patients in relation to prognostic parameters.

PFS OS
HR 95%CI P HR 95%CI P
P-LCR (<36.7 VS ≥36.7) 0.263 0.087-0.794 0.018 0.578 0.363-0.919 0.020
Sex 0.460 0.206-1.030 0.059 1.046 0.662-1.653 0.864
Age (year) 0.998 0.966-1.031 0.898 1.015 0.996-1.033 0.116
bone marrow blast (%) 1.001 0.914-1.096 0.986 1.083 1.042-1.126 P<0.001
WBC (×109/L) 1.063 0.900-1.256 0.472 1.051 0.955-1.157 0.309
ANC (×109/L) 1.072 0.856-1.342 0.547 1.023- 0.893-1.173- 0.742
Hb (g/L) 1.014 0.997-1.032 0.116 1.007 0.997-1.017 0.148
PLT (×109/L) 0.993 0.987-1.000 0.057 0.997 0.994-0.999 0.018
IPSS scores 1.319 0.781-2.228 0.300 1.530 1.160-2.018 0.003

CI, confidence interval; HR, hazard ratio; PLT, platelet count; PFS, progression-free survival; OS, overall survival.